| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Daito Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,312.00 |
| 52 Week High | JP¥2,573.00 |
| 52 Week Low | JP¥1,803.00 |
| Beta | 0.28 |
| 11 Month Change | 1.63% |
| 3 Month Change | -8.18% |
| 1 Year Change | 10.53% |
| 33 Year Change | -23.28% |
| 5 Year Change | -15.93% |
| Change since IPO | 86.50% |
Recent News & Updates
Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture
Jul 19
Shareholder Returns
| 4577 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -2.7% | -1.0% | -5.2% |
| 1Y | 10.5% | 15.8% | 15.7% |
Return vs Industry: 4577 underperformed the JP Pharmaceuticals industry which returned 15.8% over the past year.
Return vs Market: 4577 underperformed the JP Market which returned 15.7% over the past year.
Price Volatility
| 4577 volatility | |
|---|---|
| 4577 Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 4577 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4577's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1942 | 1,011 | Yasunobu Otsuga | www.daitonet.co.jp |
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. It offers generic drugs, active pharmaceutical ingredients, and over the counter drugs; and contract manufacturing services for formulations products, high-potent drugs, and packaging.
Daito Pharmaceutical Co.,Ltd. Fundamentals Summary
| 4577 fundamental statistics | |
|---|---|
| Market cap | JP¥35.14b |
| Earnings (TTM) | JP¥3.30b |
| Revenue (TTM) | JP¥46.90b |
10.7x
P/E Ratio0.8x
P/S RatioIs 4577 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4577 income statement (TTM) | |
|---|---|
| Revenue | JP¥46.90b |
| Cost of Revenue | JP¥37.06b |
| Gross Profit | JP¥9.84b |
| Other Expenses | JP¥6.54b |
| Earnings | JP¥3.30b |
Last Reported Earnings
May 31, 2024
Next Earnings Date
Oct 11, 2024
| Earnings per share (EPS) | 215.46 |
| Gross Margin | 20.98% |
| Net Profit Margin | 7.03% |
| Debt/Equity Ratio | 12.9% |
How did 4577 perform over the long term?
See historical performance and comparison